Form D · Other Technology
Tulea Health, Inc.
San Francisco, CA · CIK 0002089595
Offering snapshot reported Oct 2, 2025 · SEC filing
- Reported sold
- $10M Offering amount: $15M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 18, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 2, 2025 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-559521
Source: Form D, filed Oct 2, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steve Bence | Director, Executive |
| Ambar Bhattacharyya | Director |
| Josh Flum | Director |
| Alon Krashinsky | Director, Executive |
| Andy Mauer | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
548 Market Street. Ste 17462
San Francisco, CA, 94104
San Francisco, CA, 94104